SUGAMMADEX-DR REDDY'S, SUGAMMADEX-DRLA, SUGAMMADEX-REDDY'S, SUGAMMADEX-RZ (Dr Reddys Laboratories Australia Pty Ltd)
Product name
SUGAMMADEX-DR REDDY'S, SUGAMMADEX-DRLA, SUGAMMADEX-REDDY'S, SUGAMMADEX-RZ
Date registered
Evaluation commenced
Decision date
Approval time
123 (255 working days)
Active ingredients
sugammadex sodium
Registration type
New generic medicine
Indication
SUGAMMADEX-DR REDDY'S, SUGAMMADEX-DRLA, SUGAMMADEX-REDDY'S, SUGAMMADEX-RZ (solution for injection) is indicated for reversal of neuromuscular blockade induced by rocuronium or vecuronium.
Registration process
First generic
First approval of a medicine that contains the same active ingredient as and is bioequivalent to an existing medicine